logo
Plus   Neg
Share
Email

Inchcape To Sell 3 Retail Sites In Mainland China For £54 Mln

Inchcape Plc (INCH.L), a multi-brand automotive distributor and retailer, announced Wednesday that it has agreed to sell three Retail sites in mainland China to China Yongda Automobiles Services Holdings Ltd. for net cash proceeds of 54 million pounds.

The sites comprise Lexus in Shaoxing, Porsche in Nanchang and Mercedes-Benz in Jiujiang. China has been Inchcape's only exposure to Retail-only operations in Asia and this transaction will see the Group exit China.

The deal is expected to complete by the first quarter of 2020 and is conditional upon final OEM partner /and regulatory approvals.

The company expects minimal impact to 2019's trading profit with the business expected to contribute about 9 million pounds to Group trading profit.

The company recently announced the sale of sites in Australia and the UK to optimise Retail-only portfolios. With these together, Inchcape will receive a cash inflow of about 150 million pounds through the disposal of the combined 16 sites.

The latest sale is consistent with its focus on core Distribution capabilities.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
PG&E agreed to pay around $13.5 billion to settle all individual claims related to California wildfires, due to which the electric utility had to file for bankruptcy. With the Bankruptcy Court's approval of the settlement agreement, PG&E hopes to emerge from Chapter 11 by the June 30, 2020 deadline to participate in the State of California's go-forward wildfire fund. Airbnb has introduced few new rules to control parties and nuisances amidst the backlash the service received after the Halloween shooting at an Airbnb rental in a San Francisco. San Francisco-based Airbnb said it is banning "open invite" parties at all of its accommodations. The company is also banning... The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director...
Follow RTT
>